Leflunomide and thrombocytopenia Patient Reports February 11, 2012

Leflunomide Side Effects Report #5079193-1
Leflunomide side effect was reported by a Physician from AUSTRIA on July 26, 2006. Female patient, 66 years of age, was diagnosed with rheumatoid arthritis  and was treated with Leflunomide. After drug was administered, patient experienced the following side effects: infection , leukopenia, mucosal inflammation, myelodysplastic syndrome, pyrexia, sepsis , thrombocytopenia. Leflunomide dosage: unknown. During the same period patient was treated with ATACAND HCT, THYREX, PANTOPRAZOLE. Patient was hospitalized. Patient recovered.

Leflunomide Side Effects Report #5766852-8
Leflunomide side effect was reported by a Physician from UNITED STATES on May 29, 2008. Female patient, 51 years of age, was diagnosed with nephropathy and was treated with Leflunomide. After drug was administered, patient experienced the following side effects: dialysis , ecchymosis, graft loss, thrombocytopenia, thrombotic microangiopathy. Leflunomide dosage: unknown. During the same period patient was treated with ANTITHYMOCYTE IMMUNOGLOBULIN, TACROLIMUS, MYCOPHENOLATE MOFETIL, CORTICOSTEROIDS, RITUXAN, IMMUNE GLOBULIN INTRAVENOUS. Patient recovered.

Leflunomide Side Effects Report #5772026-7
Leflunomide side effect was reported by a Consumer or non-health professional from UNITED STATES on June 04, 2008. Female patient, 51 years of age, was treated with Leflunomide. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood lactate dehydrogenase increased, ecchymosis, off label use, thrombocytopenia, thrombotic microangiopathy. Leflunomide dosage: unknown. During the same period patient was treated with TACROLIMUS, THYMOGLOBULIN, MYCOPHENOLATE MOFETIL. Patient recovered.

Leflunomide Side Effects Report #5794740-X
Leflunomide side effect was reported by a Consumer or non-health professional from UNITED STATES on June 17, 2008. Female patient, 51 years of age, was treated with Leflunomide. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood lactate dehydrogenase increased, ecchymosis, haemolysis, off label use, overdose, thrombocytopenia, thrombotic microangiopathy. Leflunomide dosage: unknown. During the same period patient was treated with TACROLIMUS, THYMOGLOBULIN, MYCOPHENOLATE MOFETIL, CORTICOSTEROIDS, IVIGG, RITUXIMAB. Patient was hospitalized. Patient recovered.